Transaction #19701 · Form 4 · 0001193125-25-319649
Vera Therapeutics, Inc. · Purchase · Class A Common Stock
Vera Therapeutics, Inc. · Transacted December 11, 2025 · Filed December 15, 2025
What does this filing report?
An SEC Form 4 filing for Vera Therapeutics, Inc. records a purchase involving Class A Common Stock on December 11, 2025. The reported quantity was 5,882. The filing date is December 15, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Vera Therapeutics, Inc.
- Company CIK
- 0001831828
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 5,882
- Reported price
- 42.5
- Reference value
- 249,985
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 5,882
- Ownership description
- Not reported
- SEC acceptance time
- Dec 15, 2025, 8:07 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- ENRIGHT PATRICK G ↗
Director
CIK 0001253886
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- These shares are held by Longitude Prime Fund, L.P. ("LPF"). Longitude Prime Partners, LLC ("LPP") is the general partner of LPF and may be deemed to have voting and dispositive power over the securities held by LPF. The Reporting Person and Juliet Tammenoms Bakker are the managing members of LPP and may be deemed to share voting and dispositive power over the shares held by LPF. Each of LPP, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- F2
- These shares are held by Longitude Venture Partners IV, L.P ("LVPIV"). Longitude Capital Partners IV, LLC ("LCPIV") is the general partner of LVPIV and may be deemed to have voting and dispositive power over the shares held by LVPIV. The Reporting Person and Ms. Tammenoms Bakker are managing members of LCPIV and may be deemed to share voting and dispositive power with respect to the shares held by LVPIV. Each of LCPIV, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.